Lepu Biopharma Co., Ltd. (LEPU BIO-B) reported no changes to its share capital structure for the month ended 31 May 2026, according to the company’s monthly return filed with Hong Kong Exchanges and Clearing Limited on 1 June 2026.

Key highlights:

• Authorised and issued share capital stable: The company’s authorised and issued ordinary H shares stood unchanged at 1.80 billion, each with a par value of RMB 1. Corresponding registered share capital remained at RMB 1.80 billion.

• Zero treasury shares: LEPU BIO-B held no treasury shares during the period.

• No new equity instruments: The firm reported no movements in share options, warrants, convertible securities, or other equity-linked instruments.

• Public float compliance: The company confirmed adherence to the Main Board’s minimum 25% public float requirement as at 31 May 2026.

• Governance confirmation: All statutory and regulatory obligations related to any securities issuance—and the absence thereof—were affirmed by Joint Company Secretary Ms. Li Yunyi.

With capital structure steady and regulatory compliance affirmed, LEPU BIO-B enters June 2026 with 1.80 billion issued H shares fully in public circulation and no outstanding dilutive instruments.